Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: I still think PTSC will be a big winner, starting with the first re-exam

You may be right.

IMO, it would be reasonable for the J3 agreements to make payments (size and date) contingent on the outcome of the re-exam. 

J3 $ were certainly not in this 10Q.

Share
New Message
Please login to post a reply